# Regulatory Assurance Exceptions, Deficiency Aggregation & Enterprise Issue Escalation

Release 58 converts Release 57 failed samples and exceptions into a governed deficiency-management layer. It preserves immutable sample/test provenance and creates versioned control deficiencies, cross-entity enterprise issue candidates, SLA-driven escalation, compensating-control and remediation links, and independent human closure after retest evidence.

## Traceability
`sample failure -> exception -> deficiency -> enterprise issue -> remediation -> retest -> independent human closure`

## Safety boundary
AI and workers may classify, correlate, score, summarize, monitor and recommend. They may not declare a formal material weakness, conclude formal control effectiveness, approve remediation, accept residual risk, certify closure, alter accounting records, authorize payments, collect funds, or move money.

## Enterprise issue criteria
High-severity repeated exceptions and cross-entity propagation may create a *candidate* material-weakness signal. Candidate status is analytical only; an authorized independent human must escalate or dispose of the issue.

## Operational controls
- tenant-scoped persistence and retrieval
- immutable deficiency versions and closure versions
- segregation of duties between deficiency preparation and closure
- required retest evidence before a remediated conclusion
- SLA aging for enterprise issues
- SHA-256 payload fingerprinting for deficiency versions
